Long Range Planning in Canada

Transcription

1 Canada s National Laboratory for Particle and Nuclear Physics Laboratoire national canadien pour la recherche en physique nucléaire et en physique des particules Long Range Planning in Canada NSERC Long Range Plan for Subatomic Physics TRIUMF Five-Year Plan Reiner Krücken Science Division Head TRIUMF Professor of Physics University of British Columbia Owned and operated as a joint venture by a consortium of Canadian universities via a contribution through the National Research Council Canada Propriété d un consortium d universités canadiennes, géré en co-entreprise à partir d une contribution administrée par le Conseil national de recherches Canada

2 Current NSERC Long Range Plan Developed by 11 member committee (2 international) w/ community consultation Offset with TRIUMF Five-Year Plan Plan informs NSERC SAP Evaluation Section that allocates funding envelope (~$22M per year) to SAP applicants (~240 grant eligible scientists) TRIUMF in its efforts to support the Canadian SAP community For details of current plan see N. Lockyer s presentation to this group in Aug or web page: SAP = subatomic physics = Particle & Nuclear Physics IUPAP WG9 AGM 2

3 Nuclear Physics in Canada Canadian subatomic physics is healthy with: SNOLAB (double-beta decay: SNO+, potential G3 experiment + DM Experiments + HALO)) Perimeter Institute (at the forefront of theoretical developments for Particle Physics, Cosmology, Quantum Information) TRIUMF (RIB program in nuclear structure, astrophysics, fundamental symmetries & major infrastructure upgrade ARIEL) Involvement in external nuclear physics programs JLAB (Qweak, GlueX, Moller), J-PARC (g-2, COMET) Low Energy Nuclear Physics Experiments in North America, Europe, Asia EXO-200 double beta decay with aim to bring nexo to SNOLAB Distributed nuclear theory efforts at TRIUMF and universities Steady funding for subatomic physics through NSERC with additional major infrastructure investment through Canada Foundation for Innovation Hoping for small growth through recent additional funding to NSERC Challenge: Execute on promises within fiscal boundaries IUPAP WG9 AGM 3

4 SNOLAB Operated in the Creighton nickel mine, near Sudbury, Ontario, hosted by Vale. Underground campus at 6800 level, 0.27μ/m 2 /day Entire lab at class-2000, or better, to mitigate against background contamination of experiments. Focus on kilo-tonne dark matter, double beta decay, solar & SN neutrino experiments requiring depth and cleanliness courtesy N. Smith IUPAP WG9 AGM 4

5 Next NSERC SAP Long Range Plan ( ) The next NSERC Subatomic Physics Long Range Plan exercise of the Canadian Subatomic Physics community, covering the period , will be launched in early 2015 Long Range Plan Committee (LRPC) to be established by spring 2015 Consultation process of the community expected to start spring/summer 2015 through calls to the Canadian Institute for Nuclear Physics (CINP) and Institute for Particle Physics (IPP) to prepare briefs by fall 2015 LRPC will consult with community through summer 2016 Long Range Plan to be submitted to NSERC by end of 2016 IUPAP WG9 AGM 5

6 TRIUMF Five-Year Plan Realizing The Vision IUPAP WG9 AGM 6

7 TRIUMF: A National Science Laboratory Members University of Alberta University of BC University of Calgary Carleton University University of Guelph University of Manitoba Université de Montréal Queen s University Simon Fraser University University of Toronto University of Victoria York University Associate Members McGill University McMaster University University of Northern BC University of Regina Saint Mary s University University of Winnipeg TRIUMF is owned & operated by a consortium of 18 universities Founded 45 years ago in Vancouver TRIUMF receives core operational funding from the federal government through a contribution agreement via the National Research Council IUPAP WG9 AGM 7

8 TRIUMF s Research Program & Vision IUPAP WG9 AGM 8

9 TRIUMF accelerator complex TRIUMF Accelerators: 500 MeV, 350 A,H - cyclotron 4 medical isotopes cyclotrons (TR13,CP42,TR30x2) ISAC 50kW ISOL facility RFQ, 3 A/q < 30 DTL, A/q 7, MeV/u 40 MV Heavy Ion SC linac ARIEL e-linac (10mA, 50 MeV) RFQ DTL ARIEL Facility ISAC-II SRF Linac ISAC- I ISAC Targets Rare Isotope Science Nuclear Medicine Meson Hall TR13 50 MeV Electron Linac 500 MeV H - Cyclotron Molecular & Materials Science IUPAP WG9 AGM 9

10 Five-Year Plan OVERARCHING GOALS: Sustain Canadian efforts in particle & nuclear physics Advance science, technology, and business of isotopes for science & medicine Revitalize TRIUMF s core infrastructure and secure its role in attracting & retaining talent Level of achievement is set by level of core operating funds provided via NRC Contribution Agreement IUPAP WG9 AGM 10

11 SAP Science Priorities in 5YR Plan The 5-Year Plan allows to realize the vision for a forefront rare isotope science program with ISAC and ARIEL Nuclear Structure, Nuclear Astrophysics, Fundamental Symmetries continued leading involvement in international particle physics projects and breakthrough discoveries top priorities: ATLAS, T2K, ALPHA important involvements: DEAP, nexo building the vision of the Electric Dipole Moment Lab neutron (UCN/nEDM), atom (RnEDM), and evtl. electron (FrEMD) elevating Canada s leadership in accelerator science through world-leading user program and strong accelerator research and education IUPAP WG9 AGM 11

12 ISAC Rare Isotope Facility ARIEL IUPAP WG9 AGM 12

13 ISAC rare isotope facility Programs in ISAC II: > 6 AMeV for A<150 Nuclear Structure & Dynamics Nuclear Astrophysics Electroweak Interaction Studies Material Science ISAC I: 60 kev & 1.7 AMeV ~3500 RIB hours /yr ISOL facility with highest primary beam intensity (100 A, 500 MeV protons) target materials: Si, Ti, Ni, Zr, Nb, Ta, U IUPAP WG9 AGM 13

14 ISAC experimental facilities TITAN Penning Trap facility EMMA recoil mass analyzer (2015) TIGRESS in-beam gamma-ray spectrometer Nuclear Structure Nuclear Astrophysics MTV Mott scattering drift chamber Fundam. Symmetries IRIS solid hydrogen reaction set-up (2012) DRAGON recoil separator Laser polarizer line Francium trapping facility (2012) TRINAT magneto optical trap DESCANT GRIFFIN TUDA reaction setup IUPAP WG9 AGM 14 14

15 Advanced Rare IsotopE Laboratory (ARIEL) ARIEL is TRIUMF s flagship: Isotopes for Science & Medicine e-linac ISAC Existing ARIEL I (CFI+BCKDF) ARIEL II (CFI proposal by 19 universities) Cyclotron IUPAP WG9 AGM Substantially expands Canadian capabilities Three simultaneous RIB beams More time for science with world leading instrumentation More and new isotopes for Nuclear Physics Nuclear Astrophysics Fundamental Symmetries Materials Science Nuclear Medicine More national & international users Phased implementation interleaving science with construction 15

16 ARIEL Building Completion Culmination of 3 years work Meets needs of entire ARIEL scope IUPAP WG9 AGM 16

17 e-linac Progress Klystrons Cryogenics infrastructure LHe cold box e-gun HV power supply Beamline magnets e-gun and injector cryomodule E-gun and injector cryomodule (ICM) installed in e-hall Commissioning started (CNSC license for 3kW) 10mA extracted from source, injector cavity reached 5MV/m On track for fall delivery of 25MeV, 100kW beam IUPAP WG9 AGM 17

18 5YP : ARIEL-II Completion of ARIEL is TRIUMF s flag-ship project Enable RIB science with multiple beams & multiple production techniques Enables full exploitation of 18 experimental facilities Facilitates medical isotope research with alpha emitters ( 211 At, 225 Ac) CFI funding proposal (ARIEL-II) is being led by Univ. Victoria & will be submitted to CFI Innovation Fund universities participating (one non-member) (unprecedented!) $33.8M total project cost IUPAP excluding WG9 AGM manpower (coming from 18

19 ARIEL Timeline June 2010 ARIEL Project begins August 2013 ARIEL Building complete June 2014 ARIEL-II CFI application September, 2014 e-linac Phase 1 Complete March 2015 ARIEL-II CFI decision ARIEL-II Phase 2 Photofission r-process ARIEL-II Phase 3 (CANREB) Pure High Mass accel. RIBs Medical isotopes collection station ARIEL-II Phase kw Extend r-process reach August 2013 TRIUMF-VECC MOU Add-3 signed ARIEL-II Phase 1 Materials Science at -NMR ARIEL-II Phase 4 (extra proton beamline) Fundamental Symmetries Two ARIEL beams IUPAP WG9 AGM 19

20 Complete ARIEL and tap its unique capabilities for isotope production Unified theory for all nuclei - halo / dripline nuclei & ab-inito theory high power proton beam - shell evolution and 3N forces high power electron beam New proton spallation beam line on UC Origin of the heavy elements - H & He burning High power proton beam Beam development time Long beam times - r-process in neutron-rich nuclei High power electron beam Fundamental Symmetries - Francium and Radon EDMs and PNC High power proton beam Long beam times Photo-fission on U-target Need high-power proton and electron production in full multi-user operation w/ 3 production targets Increase of high-impact science, publications, HQP IUPAP WG9 AGM 20

21 Ultra Cold Neutron Facility to measure the Neutron Electric Dipole Moment IUPAP WG9 AGM 21

22 Future Ultra Cold Neutron facility strong Japan-Canada collaboration (KEK, RCNP, Winnipeg, Manitoba, UCN) He-II source concept developed and being tested at RCNP Small room temperature EDM apparatus with dual co-magnetometer Installation of new beam line and source at TRIUMF 2014/5, source in 2016 Aim is for 3000 UCN/cm 2, 2014: Installation of new beamline started nedm experiment 2016: start of nedm program (1-20 A) : Expand cooling capacity (40 A) kicker BL1U BL1A UCN source ~ 2020: world leading nedm sensitivity (~10-28 e cm) IUPAP WG9 AGM 22

23 Nuclear Medicine Regional Centre of Excellence for Nuclear Medicine Accelerator based production of 99m Tc IUPAP WG9 AGM 23

24 TRIUMF Nuclear Medicine Core Competency: Targets/Nuclear Chemistry High power solid targets for medical cyclotrons 99m Tc production to address isotope crisis - flagship effort cooperations (BC Cancer Agency, private sector) Core Competency: Isotope Production 18 F/ 11 C production and use (e.g. Pacfic Parkinson Research Centre) Radiometal production ( 89 Zr, 68 Ga, 44 Sc, 88 Y, 55 Co, 52 Mn) Exploiting ISAC/ARIEL capabilities ( 209,211 At, 225 Ac, 213 Bi) Core Competency: Radiochemistry PPRC-Neurology: New tracers to support new efforts in non-dopamine neurotransmitter research Developing new ideas & novel applications 24

25 Institute for Accelerator-based Medical Isotopes (IAMI) TR Medical Cyclotrons Made in BC New TR24 cyclotron purchased with federal funding (Western Economic Diversification) courtesy Paul Schaffer IUPAP WG9 AGM 25

26 Adrressing the 99m Tc isotope crisis NRU reactor will stop producing 99 Mo in 2016 (currently produces ~40% of global supply) Natural Resources Canada (NRCan) funded Isotope Technology Acceleration Program ( ITAP): 4 years (ending 2016), $35M, 3 proponents funded TRIUMF consortium [proton cyclotron: 100 Mo(p,2n) 99m Tc] ERC consortium [proton cyclotron: 100 Mo(p,2n) 99m Tc] CLS/PIPE effort [electron linac: 100 Mo(,n) 99 Mo] 2 2 IUPAP WG9 AGM 26

27 Decentralized 99m Tc Production in Canada TRIUMF led effort concentrates on using network of existing PET cyclotrons 99m Tc demand of metropolitan regions could be served by distributed supply production during the night for next day supply of 99m Tc 2 2 IUPAP WG9 AGM 27

28 Cyclotron Produced 99m Tc NRCan ITAP project (TRIUMF, BCCA, Lawson Health, CPDC) Full production cycle has been demonstrated Sufficient production for metropolitan area (e.g. Vancouver) demonstrated (ACSI TR-19 & GE PETtrace) validates business proposition that conventional cyclotrons around the world can be upgraded to produce Tc-99m for their respective region TRIUMF/AAPS spin-off company ARTMS TM formed to supply 100 Mo-coated solid cyclotron targets from centralized generator production to local on demand production IUPAP WG9 AGM 28

29 TRIUMF Five-Year Plan Realizing The Vision IUPAP WG9 AGM 29

30 International Peer Review Nov , 2013 International Peer Review Committee (IPRC) Dr. Samuel Aronson (BNL) (chair) Dr. Juha Äystö (Helsinki IPP) Ms. Frenny Bawa (Nanotech Security Corp) Dr. Silvia Jurisson (Missouri) Dr. Barbara Jones (IBM Almaden) Dr. Robert McGreevy (ISIS RAL) Dr. Hugh Montgomery (JLAB) Dr. Jerry A. Nolen (ANL) Dr. Maury Tigner (Cornell) Overarching finding: The IPRC found TRIUMF s research activities during the period to be world class and meeting or exceeding the expectations of TRIUMF s plan for that period. Recommendation: The IPRC unanimously endorses the goals of the Year Plan and recommends fully funding TRIUMF s request. [ $290 M] IUPAP WG9 AGM 30

31 TRIUMF s Budget Situation Federal Budget 2014 announced $222M commitment to TRIUMF for through NRC Contribution Agreement early announcement of core funding is pioneering---and very welcome budget certainty provides competitive advantage and planning stability Flat funding secures continued efforts in key areas of particle and nuclear physics TRIUMF is working to identify and secure additional funding to seize the moment in rare isotope research, being first on key measurements; enhance applied research areas of nuclear medicine and materials science; increase opportunities for commercialization & technology transfer. IUPAP WG9 AGM 31

32 Conclusion Canadian SAP enjoys stable funding, preparing for Long Range Planning exercise for LRP TRIUMF has put forward an ambitious plan for that has full support of community and International Peer Review Completion of ARIEL is TRIUMF s flagship project for the next Five Year Plan. International engagement in major science endeavors remains a priority TRIUMF has secured flat operating funds for core operations during and is working to secure additional funding to deliver ambitious plan IUPAP WG9 AGM 32

33 Canada s National Laboratory for Particle and Nuclear Physics Laboratoire national canadien pour la recherche en physique nucléaire et en physique des particules TRIUMF: Alberta British Columbia Calgary Carleton Guelph Manitoba McMaster McGill Montréal Northern British Columbia Queen s Regina Saint Mary s Simon Fraser Toronto Victoria Winnipeg York Thank you! Merci! Owned and operated as a joint venture by a consortium of Canadian universities via a contribution through the National Research Council Canada Propriété d un consortium d universités canadiennes, géré en co-entreprise à partir d une contribution administrée par le Conseil national de recherches Canada